In the article published in the FASEB Journal,in February 2016,(1), we can read that:
"Antagonizing or inhibiting GSK3β can rescue the β-cell defects." (helping in the treatment of diabetes mellitus).
As we can see bellow (1), the Acetyl L Carnitine (ALCAR)in very small doses, is an effective peroxinitrites scavenger,improves mitochondrial function,is a heavy metal chelator,improves brain energy, lowers tau and betamyloid accumulation in the brain,is a GSK3β inhibitor , that can helps as a support therapy in the treatment of diabetes mellitus too.
1) FASEB Journal,in February 2016,with the title “Beyond the Brain: disrupted in Schizophrenia 1 Regulates Pancreatic β-cell Function Via Glycogen Synthase Kinase-3β” by Agata Jurczyk and colleagues ,
2) J Neurochem. 2011 - Acetyl-L-Carnitine Ameliorates Spatial Memory Deficits Induced by Inhibition of Phosphoinositol-3 Kinase and Protein Kinase C. Jiang X : "Feeding the rats with Acetyl-L-Carnitine (ALCAR, 50 mg/day•rat, per os) for 2 weeks rescued the WT/GFX-induced spatial memory retention impairment of the rats by antagonizing GSK-3β activation"